CIK 0000885725
- Large accelerated filer
BOSTON SCIENTIFIC CORP
Sign in to watch- Ticker
- BSX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042695240
- Phone
- +1 508-683-4000
- Business address
- 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA, 01752-1234
- Open-market buys, last 90 days
- $100,408
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$100,408. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-16 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Grant or award · Restricted Stock Units | +9,051 | 9,051 | ||
| 2022-02-16 | Thepaut Eric Francis Yves EVP & Pres, Eur, Mid-East, Afr | Grant or award · Stock Option (Right to Buy) | +25,882 | 25,882 | ||
| 2022-02-16 | Sorenson John Bradley SVP, Global Supply Chain | Grant or award · Restricted Stock Units | +5,091 | 5,091 | ||
| 2022-02-16 | Sorenson John Bradley SVP, Global Supply Chain | Grant or award · Stock Option (Right to Buy) | +14,558 | 14,558 | ||
| 2022-02-16 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Restricted Stock Units | +8,486 | 8,486 | ||
| 2022-02-16 | Scanlon Meghan SVP,Pres,Urology Pelvic Health | Grant or award · Stock Option (Right to Buy) | +24,264 | 24,264 | ||
| 2022-02-16 | Pierce David A EVP Pres MedSurg | Sale | −1,956 | $43.81 | $86K | 0 |
| 2022-02-16 | Olson Scott SVP & Pres, CRM, Diagnostics | Grant or award · Restricted Stock Units | +5,374 | 5,374 | ||
| 2022-02-16 | Olson Scott SVP & Pres, CRM, Diagnostics | Grant or award · Stock Option (Right to Buy) | +15,367 | 15,367 | ||
| 2022-02-16 | Nanavaty Maulik SVP & Pres, Neuromodulation | Grant or award · Restricted Stock Units | +7,354 | 7,354 | ||
| 2022-02-16 | Nanavaty Maulik SVP & Pres, Neuromodulation | Grant or award · Stock Option (Right to Buy) | +21,029 | 21,029 | ||
| 2022-02-16 | Monson Jonathan VP, Global Controller and CAO | Grant or award · Restricted Stock Units | +3,960 | 3,960 | ||
| 2022-02-16 | Monson Jonathan VP, Global Controller and CAO | Grant or award · Stock Option (Right to Buy) | +13,180 | 13,180 | ||
| 2022-02-16 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Grant or award · Restricted Stock Units | +11,880 | 11,880 | ||
| 2022-02-16 | Mirviss Jeffrey B. EVP&Pres, Periph Intervent | Grant or award · Stock Option (Right to Buy) | +33,970 | 33,970 | ||
| 2022-02-16 | Meredith Ian T EVP Global Chief Med Officer | Grant or award · Restricted Stock Units | +4,525 | 4,525 | ||
| 2022-02-16 | Meredith Ian T EVP Global Chief Med Officer | Grant or award · Stock Option (Right to Buy) | +12,941 | 12,941 | ||
| 2022-02-16 | Mahoney Michael F Chairman, President & CEO | Grant or award · Restricted Stock Units | +65,059 | 65,059 | ||
| 2022-02-16 | Mahoney Michael F Chairman, President & CEO | Grant or award · Stock Option (Right to Buy) | +186,029 | 186,029 | ||
| 2022-02-16 | Fitzgerald Joseph Michael EVP & Pres, Cardiology | Grant or award · Restricted Stock Units | +15,840 | 15,840 |
Page 80 of 87 · 1,736 trades